6-Hydroxydopamine lesions of nucleus accumbens core abolish amphetamine-induced conditioned activity

Synapse

Volumn 59, Issue 6, 2006, Pages 374-377

  Sellings, Laurie H L ^a   Clarke, Paul B S ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

6 hydroxydopamine; Accumbens; Amphetamine; Conditioned locomotion; Core; Shell; Striatum

Indexed keywords

AMPHETAMINE; DOPAMINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DAMAGE; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; ENVIRONMENTAL FACTOR; INFORMATION PROCESSING; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; COCAINE; CONDITIONING, OPERANT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; OXIDOPAMINE; RADIOPHARMACEUTICALS; RATS; RATS, LONG-EVANS; SYMPATHOLYTICS; TRITIUM;

EID: 33645417554     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20247     Document Type: Article

References (17)

1. Bardo MT, Bevins RA. 2000. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31-43.
2. Beninger RJ, Hahn BL. 1983. Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science 220:1304-1306.
3. Berridge CW, Stratford TL, Foote SL, Kelley AE. 1997. Distribution of dopamine b-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 27:230-241.
4. Brown EE, Fibiger HC. 1993. Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference. Psychopharmacology 113:123-130.
5. Delfs JM, Zhu Y, Druhan JP, Aston-Jones GS. 1998. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res 806:127-140.
6. DiLullo SL, Martin-Iverson MT. 1991. Presynaptic dopaminergic neurotransmission mediates amphetamine-induced unconditioned but not amphetamine-conditioned locomotion and defecation in the rat. Brain Res. 568:45-54.
7. DiLullo SL, Martin-Iverson MT. 1992a. Calcium channel blockade interacts with a neuroleptic to attenuate the conditioning of amphetamine's behavioral effects in the rat. Biol Psychiatry 31:1143-1150.
8. DiLullo SL, Martin-Iverson MT. 1992b. Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion. Brain Res. 578:161-167.
9. Gold LH, Swerdlow NR, Koob GF. 1988. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine. Behav Neurosci 102:544-552.
10. Hemby SE, Jones GH, Justice JB, Jr., Neill DB. 1992. Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine. Psychopharmacology 106:330-336.
11. Hotsenpiller G, Horak BT, Wolf ME. 2002. Dissociation of conditioned locomotion and Fos induction in response to stimuli formerly paired with cocaine. Behav Neurosci 116:634-645.
12. Jones GH, Robbins TW. 1992. Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity. Pharmacol Biochem Behav 43:887-895.
13. 2 dopamine receptors during conditioning. Brain Res 521:175-184.
14. Mazurski EJ, Beninger RJ. 1991. Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats. Psychopharmacology 105:107-112.
15. Poncelet M, Dangoumau L, Soubrie P, Simon P. 1987. Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats. Psychopharmacology 92:393-397.
16. Sellings LH, Clarke PB. 2003. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J Neurosci 23:6295-6303.
17. Sutton MA, McGibney K, Beninger RJ. 2000. Conditioned locomotion in rats following amphetamine infusion into the nucleus accumbens: blockade by coincident inhibition of protein kinase A. Behav Pharmacol 11:365-376.